As was shown in Fig. 1A, serum Nrg4 level was significantly higher in control compared to CAD patients (SAP + ACS) (1.1 ± 0.9 ng/mL versus 0.7 ± 0.53 ng/mL, P = 0.018). Here, NRG4 is linked to coronary artery disorder.